Lung Transplant Outcomes Following Treatment of Pre‐Transplant MAC Pulmonary Infection
The role of treatment for MAC infection pre-transplant is questionable, especially in patients with diseases like ILD who may not have enough wait time to complete therapy.
Authors
- Ian A. Makey (ORCID: https://orcid.org/0000-0002-8380-0331)
- Maher A. Baz (ORCID: https://orcid.org/0000-0001-6784-8071)
- Tathagat Narula (ORCID: https://orcid.org/0000-0003-4631-9888)
- Remzi Bag (ORCID: https://orcid.org/0000-0001-8313-6015)
- Francisco Alvarez (ORCID: https://orcid.org/0000-0002-3692-9757)
- Prasanth Balasubramanian (ORCID: https://orcid.org/0000-0002-8963-1583)
- Wendelyn Bosch (ORCID: https://orcid.org/0000-0003-3021-2752)
- Kelly M. Pennington (ORCID: https://orcid.org/0000-0003-1187-5059)
- Lisa Brumble (ORCID: https://orcid.org/0000-0001-5761-7309)
- Margaret Johnson (ORCID: https://orcid.org/0000-0003-1330-7100)
- Sadia Shah (ORCID: https://orcid.org/0000-0002-5934-0013)
- Aditya Khanijo (ORCID: https://orcid.org/0009-0000-3536-7468)
- Mathew Thomas
- John C. Haney (ORCID: https://orcid.org/0009-0001-4002-0909)
- B A White
- Rosa Corro
Institutions
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1111/tid.70129
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00